| __timestamp | Agios Pharmaceuticals, Inc. | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 85181000 |
| Thursday, January 1, 2015 | 141827000 | 135253000 |
| Friday, January 1, 2016 | 220163000 | 162297000 |
| Sunday, January 1, 2017 | 292681000 | 198442000 |
| Monday, January 1, 2018 | 341324000 | 226616000 |
| Tuesday, January 1, 2019 | 410894000 | 299726000 |
| Wednesday, January 1, 2020 | 367470000 | 335375000 |
| Friday, January 1, 2021 | 256973000 | 505748000 |
| Saturday, January 1, 2022 | 279910000 | 590453000 |
| Sunday, January 1, 2023 | 288903000 | 849658000 |
| Monday, January 1, 2024 | 301286000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Jazz Pharmaceuticals plc and Agios Pharmaceuticals, Inc. have demonstrated contrasting trajectories in their R&D investments.
From 2014 to 2023, Agios Pharmaceuticals consistently increased its R&D spending, peaking in 2019 with a 310% rise from its 2014 levels. However, a slight decline was observed post-2019, with a 30% reduction by 2023. In contrast, Jazz Pharmaceuticals showed a steady increase, culminating in a remarkable 900% growth by 2023 compared to 2014. This surge highlights Jazz's strategic focus on expanding its research capabilities.
These trends underscore the dynamic nature of the pharmaceutical industry, where strategic R&D investments can significantly influence a company's market position and innovation potential.
Research and Development Investment: Novartis AG vs Jazz Pharmaceuticals plc
Pfizer Inc. vs Jazz Pharmaceuticals plc: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Agios Pharmaceuticals, Inc.
Analyzing R&D Budgets: Biogen Inc. vs Agios Pharmaceuticals, Inc.
Bio-Techne Corporation vs Jazz Pharmaceuticals plc: Strategic Focus on R&D Spending
Sarepta Therapeutics, Inc. or Agios Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development Investment: Jazz Pharmaceuticals plc vs Halozyme Therapeutics, Inc.
Research and Development Investment: Jazz Pharmaceuticals plc vs Grifols, S.A.
Analyzing R&D Budgets: Jazz Pharmaceuticals plc vs Arrowhead Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Travere Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc.